Flat optic versus diffractive lens array for 755-nm picosecond laser treatment of melasma-associated photoaging: a randomized split-face trial in Chinese women
Introduction Facial aging in Asian populations presents unique challenges, as photoaging frequently coexists with melasma, and conventional laser treatments carry elevated post-inflammatory hyperpigmentation (PIH) risk. The comparative efficacy of different 755-nm picosecond alexandrite laser (PSAL) delivery systems remains unclear. This study aims to compare the efficacy and safety of 755-nm PSAL flat optic versus diffractive lens array (DLA) for facial rejuvenation in Chinese women with Fitzpatrick skin types III-IV and melasma. Methods This randomized split-face trial enrolled 80 Chinese women with symmetrical facial photoaging and melasma. Participants received six treatment sessions at 4-week intervals followed by 24 months of follow-up. Primary outcome was the mean change in the dyschromia score from baseline to 4 weeks after the third treatment. Secondary outcomes included changes in scores for skin laxity, rhytids, and texture at all follow-up points, melasma improvement using the hemi-Melasma Area and Severity Index (hemi-MASI), patient satisfaction, histological changes and safety. Results Seventy-eight participants (mean age 42.95 ± 8.19 years) completed follow-up. Both delivery systems significantly improved photoaging and melasma. Flat optic demonstrated slightly greater pigment reduction after six sessions (mean dyschromia score: 1.60 vs. 1.65 for DLA; mean hemi-MASI score: 3.76 vs. 3.82), lower PIH incidence (35.9% vs. 60.3%, P = 0.002), and shorter recovery (60.7% recovered within 1 week vs. 27.7% requiring >4 weeks with DLA). Analysis of skin texture revealed a significant time-by-treatment interaction ( P = .02), indicating that the efficacy profiles of the two treatments differed significantly over time. Histological analysis did not detect a statistically significant difference between the groups for collagen and elastin density. Pain scores favored flat optic (4.18 vs. 5.83; P < 0.001). No significant difference was found in long-term outcomes. Discussion Flat optic PSAL offers a more favorable safety profile, characterized by lower PIH incidence and less pain, for PIH-prone patients with Fitzpatrick skin types III-IV, supporting its valuable option for treating photoaging and melasma in sensitive skin types. Clinical Trial Registration https://www.chictr.org.cn/ , Identifier ChiCTR2200065607.
Authors
- Qingqing Cen (ORCID: https://orcid.org/0000-0003-2590-0147)
- Wu PinRu
- Sun Qilin (ORCID: https://orcid.org/0000-0002-9411-9453)
- Liu Yang
- Ying Shang
- Gang Ma
- Yue Han
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Ninth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fmed.2026.2007032
- Primary Topic
- Dermatologic Treatments and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission